20S Proteasome-IN-3

Cat. No.: HY-150591: Data Sheet Handling Instructions
FAQs
Technical Support

20S Proteasome-IN-3 is a 20S proteasome β5 subunit inhibitor (IC₅₀=1.64 μM). 20S Proteasome-IN-3 shows anti-tumor proliferation activity.

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

20S Proteasome-IN-3 화학구조

CAS No. : 1803040-07-4

사이즈		재고
MOQ		Minimum order quantity
50 mg		견적 받기
100 mg		견적 받기
250 mg		견적 받기
Other size		견적 받기

* 장바구니에 담기 전 물품의 수량을 선택해 주십시오.

This product is a controlled substance and not for sale in your territory.

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
순도&문서
References
고객리뷰

제품 설명

20S Proteasome-IN-3 is a 20S proteasome β5 subunit inhibitor (IC₅₀=1.64 μM)^[1]^[2]. 20S Proteasome-IN-3 shows anti-tumor proliferation activity^[2].

IC₅₀ & Target

IC50: 1.64 μM (20S proteasome β5 subunit)^[1]

In Vitro

20S Proteasome-IN-3 (Compound 10b) (5.34-9.69 μM, 18-24 h) exhibits significant inhibition against A375, SW480, DU145, and HeLa cells^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[2]

Cell Line:	A375, SW480, DU145, and HeLa cell lines
Concentration:	5.34-9.69 μM
Incubation Time:	18-24 hours
Result:	Inhibited the proliferation of SW480, DU145, A375 and HeLa cells with the IC₅₀s of 5.34, 9.69, 5.66 and 7.03 μM, respectively.

분자량

621.72

화학식

C₃₄H₄₃N₃O₈

CAS No.

1803040-07-4

SMILES

OC(C=C1)=CC=C1C[C@@H](C(N[C@@H](CC(C)C)C(C2=CC=CO2)=O)=O)NC([C@@H](NC(OC(C)(C)C)=O)CC3=CC=C(C=C3)OC)=O

선적

Room temperature in continental US; may vary elsewhere.

보관

Please store the product under the recommended conditions in the Certificate of Analysis.

순도&문서

Handling Instructions (2659 KB)

References

[1]. Qi Sun, et al. Design and synthesis of tripeptidyl furylketones as selective inhibitors against the β5 subunit of human 20S proteasome. Eur J Med Chem. 2020 Apr 15;192:112160. [Content Brief]

[2]. Qi Sun, et al. Synthesis, bioactivity, docking and molecular dynamics studies of furan-based peptides as 20S proteasome inhibitors. ChemMedChem. 2015 Mar;10(3):498-510. [Content Brief]